GLYCODESIGN
GlycoDesign is a biopharmaceutical company, engages in the discovery and development of proprietary drugs for the treatment or prevention of cardiovascular and chronic inflammatory diseases, as well as cancer. It focuses on two anti-thrombotic drug candidates, GH9001 and ATH, as well as in the development of glycotherapeutics for the potential treatment of chronic inflammation and cancer.
GLYCODESIGN
Industry:
Biotechnology Pharmaceutical
Founded:
1993-01-01
Address:
Toronto, Ontario, Canada
Country:
Canada
Website Url:
http://www.glycodesign.com
Total Employee:
11+
Status:
Closed
Contact:
(416) 593-6027
Similar Organizations
Proacta Therapeutics
Proacta Therapeutics is a biopharmaceutical company, engages in the discovery and development of oncology drugs.
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 1999-11-08 | Vascular Therapeutics | Vascular Therapeutics acquired by GlycoDesign | N/A |
Official Site Inspections
http://www.glycodesign.com
- Host name: a904c694c05102f30.awsglobalaccelerator.com
- IP address: 13.248.169.48
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "GlycoDesign"
GLYCODESIGN INC. | Canada Corporation Directory
GLYCODESIGN INC. is a Distributing corporation corporation type, which located at 480 UNIVERSITY AVENUE SUITE 400 TORONTO ON M5G 1V2 Canada. It was registered on 30 …See details»
Glycodesign - Products, Competitors, Financials, Employees ...
May 13, 2016 GLYCODesign is a publicly traded biopharmaceutical company engaged in the discovery and clinical development of glycotherapeutics for the treatment of cardiovascular …See details»
GlycoDesign 2025 Company Profile: Valuation, Investors
What industry is GlycoDesign in? GlycoDesign’s primary industry is Drug Discovery. Is GlycoDesign a private or public company? GlycoDesign is a Private company. What is …See details»
GLYCODesign Inc Overview | SignalHire Company Profile
GLYCODesign Inc is a biotechnology company based out of 480 University Ave Suite 480, Toronto, ON, Canada. Organization Website glycodesign.comSee details»
GlycoDesign Inc - Company Profile and News - Bloomberg Markets
Company profile page for GlycoDesign Inc including stock price, company news, executives, board members, and contact informationSee details»
Glycodesign - 2025 Company Profile, Funding & Competitors
Mar 10, 2025 Glycodesign - Glycobiology-based therapeutics for thrombosis and inflammatory diseases. Acquired by Inflazyme. Raised a total funding of $11.4M over 1 round from 6 …See details»
GlycoDesign - Funding, Financials, Valuation & Investors
Nov 8, 1999 GlycoDesign is a biopharmaceutical company, engages in the discovery and development of proprietary drugs for the treatment. Search Crunchbase Start Free TrialSee details»
GlycoDesign - Crunchbase
GlycoDesign is a biopharmaceutical company, engages in the discovery and development of proprietary drugs for the treatment.See details»
GLYCODesign, Inc.:Company Profile & Technical …
Mar 3, 2023 GLYCODesign, Inc. is a company that provides Medicine, Carbohydrate, Proprietary drug and more. GLYCODesign, Inc. is headquartered in Canada Ontario. …See details»
GLYCODesign, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore GLYCODesign, Inc. with its drug pipeline, therapeutic area, technology platform, 11 literature, Drug:Swainsonine hydrochloride, V-20.See details»
BioPharmaLink profile of GlycoDesign Inc., Canada,
GlycoDesign Inc. GLYCODesign is a private, biopharmaceutical company engaged in the discovery and early stage clinical development of novel therapeutics for the treatment of …See details»
Glycodesign Therapeutics, Inc. - Drug pipelines, Patents, Clinical ...
Explore Glycodesign Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, .See details»
Glycodesign - Raised $11.4M Funding from 6 investors - Tracxn
Feb 22, 2025 Glycodesign has raised a total funding of $11.4M over 1 round from 6 investors. Investors include RBC Capital Markets, Domain Associates and 4 others. Their latest funding …See details»
GLYCODESIGN INC. :: Canada - OpenCorporates
Free and open company data on Canada company GLYCODESIGN INC. (company number 2982340), 480 UNIVERSITY AVENUE SUITE 400, TORONTO, ON, M5G 1V2. Changes to …See details»
Inflazyme Pharmaceuticals acquires GlycoDesign - 2003-04-09 ...
Apr 9, 2003 GlycoDesign GlycoDesign is a biopharmaceutical company, engages in the discovery and development of proprietary drugs for the treatment. Acquiring Organization: …See details»
GlycoDesign Asset Profile | Preqin
GlycoDesign, Inc. is a biopharmaceutical company, engages in the discovery and development of proprietary drugs. Primary Industry Biotechnology Sub Industries Biopharmaceuticals …See details»
GLYCODESIGN, INC. - US Patent and Trademark Search
GLYCODESIGN INC: uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office …See details»
Glycodesign CEO, Founder, Key Executive Team, Board of Directors ...
Explore {Glycodesign's key management people. Discover current leadership team members including founders, CEO, other executives and board directors.See details»
GlycoDesign, VTI Merge In Stock Deal Worth $10M
Aug 12, 1999 GlycoDesign Inc., a firm that develops therapeutics based on glycobiology, acquired Vascular Therapeutics Inc., which specializes in glycotherapeutics for cardiovascular …See details»